Patients with a history of cancer were more likely to suffer from obesity than the general population. This incidence was even greater in patients who were survivors of colorectal and breast cancers.
Patients with a history of cancer were more likely to suffer from obesity than the general population, according to new research studying the incidence of obesity in cancer survivors. This incidence was even greater in patients who were survivors of colorectal and breast cancers.
The study from Columbia University's Mailman School of Public Health was designed to compare rates of obesity among cancer survivors and adults without a history. By examining the trend in obesity prevalence among cancer survivors in United States and comparing the trends with those of adults without a history of cancer, the study is first of its kind. The findings are published in the Journal of Clinical Oncology.
Prevalence of Obesity for Cancer Survivors
The researchers used a population-based nationally representative sample of 538,969 non-institutionalized US adults with or without a history of cancer. All participants were between the ages of 18 and 85 years. All participants had also participated in annual cross-sectional National Health Interview Surveys from 1997 to 2014.
For standardization purposes, obesity was defined as body mass index ≥ 30 kg/m2 for non-Asians and body mass index ≥ 27.5 kg/m2 for Asians.
The key results were as follows:
Obesity a Growing Health Burden
“Our study identified characteristics of cancer survivors at the highest risk of obesity, which are important patient populations in which oncology care providers should focus their efforts,” said Heather Greenlee, ND, PhD, assistant professor of Epidemiology at the Mailman School, and lead researcher.
Patients with a history of cancer may have battled their biggest health issue but often they are left with the side-effects of the illness. The study highlights the strong link between the incidence of obesity and history of cancer. If targeted properly, these patients can be selectively and pro-actively treated for weight management and physical training in order to prevent the increasing obesity trends in cancer survivors.
“These results suggest that obesity is a growing public health burden for cancer survivors, which requires targeted interventions including weight management efforts to stave off the increasing obesity trends we are seeing in cancer survivors,” noted Greenlee.
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
FDA Approves Tislelizumab-jsgr as First-Line Therapy for HER2– Gastric Cancers
January 2nd 2025Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic HER2-negative (HER–) gastric or gastroesophageal junction adenocarcinoma (G/GEJ) in adults whose tumors express PD-L1.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen